Skip to main content
Top
Published in: Rheumatology International 10/2019

01-10-2019 | Polymyositis | Comorbidities

Clinical characteristics and prognosis of polymyositis and dermatomyositis associated with malignancy: a 25-year retrospective study

Authors: Kyoko Motomura, Hiroyuki Yamashita, Saeko Yamada, Yuko Takahashi, Hiroshi Kaneko

Published in: Rheumatology International | Issue 10/2019

Login to get access

Abstract

The objective of this study was to identify factors predictive of malignancy in patients with polymyositis (PM) and dermatomyositis (DM) in Japan. We conducted a retrospective study of PM and DM patients who were admitted to our hospital between January 1992 and September 2017. Among 134 patients, 29 (21.6%) were diagnosed with cancer in the 3 years prior to and 3 years after the initial diagnosis of PM or DM. According to multivariate analyses, male sex [odds ratio (OR) = 3.65, p = 0.03], old age (OR = 1.05, p = 0.02), and a past history of diabetes mellitus (OR = 10.4, p = 0.005) were associated with an increased risk of malignancy. The absence of interstitial lung disease (ILD) (OR = 0.25, p = 0.03) was also associated with an increased risk of malignancy. Diabetes mellitus was observed in 28.6% of PM and DM patients with malignancy, but in only 7.3% of those with malignancy. Survival was significantly lower in patients with malignancy than in those without malignancy (p < 0.001). Independent factors associated with malignancies in patients with PM or DM were male sex, old age, the absence of ILD, and, especially, a past history of diabetes mellitus.
Literature
1.
go back to reference Stertz G (1916) Polymyositis. Berl Klin Wochenschr 53:489 Stertz G (1916) Polymyositis. Berl Klin Wochenschr 53:489
2.
go back to reference Antiochos BB, Brown LA, Li Z, Tosteson TD, Wortmann RL, Rigby WF (2009) Malignancy is associated with dermatomyositis but not polymyositis in Northern New England, USA. J Rheumatol 36:2704–2710CrossRefPubMed Antiochos BB, Brown LA, Li Z, Tosteson TD, Wortmann RL, Rigby WF (2009) Malignancy is associated with dermatomyositis but not polymyositis in Northern New England, USA. J Rheumatol 36:2704–2710CrossRefPubMed
3.
go back to reference András C, Ponyi A, Constantin T, Csiki Z, Szekanecz E, Szodoray P et al (2008) Dermatomyositis and Polymyositis associated with malignancy: a 21-year retrospective study. J Rheumatol 35:438–444PubMed András C, Ponyi A, Constantin T, Csiki Z, Szekanecz E, Szodoray P et al (2008) Dermatomyositis and Polymyositis associated with malignancy: a 21-year retrospective study. J Rheumatol 35:438–444PubMed
4.
go back to reference So MW, Koo BS, Kim YG, Lee CK, Yoo B (2011) Idiopathic inflammatory myopathy associated with malignancy: a retrospective cohort of 151 Korean patients with dermatomyositis and polymyositis. J Rheumatol 38(11):2432–2435CrossRefPubMed So MW, Koo BS, Kim YG, Lee CK, Yoo B (2011) Idiopathic inflammatory myopathy associated with malignancy: a retrospective cohort of 151 Korean patients with dermatomyositis and polymyositis. J Rheumatol 38(11):2432–2435CrossRefPubMed
5.
go back to reference Fang YF, Wu YJ, Kuo CF, Luo SF, Yu KH (2016) Malignancy in dermatomyositis and polymyositis: analysis of 192 patients. Clin Rheumatol 35(8):1977–1984CrossRefPubMed Fang YF, Wu YJ, Kuo CF, Luo SF, Yu KH (2016) Malignancy in dermatomyositis and polymyositis: analysis of 192 patients. Clin Rheumatol 35(8):1977–1984CrossRefPubMed
6.
go back to reference Wang J, Guo G, Chen G, Wu B, Lu L, Bao L (2013) Meta-analysis of the association of dermatomyositis and polymyositis with cancer. Br J Dermatol 169:838–847CrossRefPubMed Wang J, Guo G, Chen G, Wu B, Lu L, Bao L (2013) Meta-analysis of the association of dermatomyositis and polymyositis with cancer. Br J Dermatol 169:838–847CrossRefPubMed
7.
go back to reference Ponyi A, Constantin T, Garami M, András C, Tállai B, Váncsa A et al (2005) Cancer-associated myositis:clinical features and prognostic signs. Ann N Y Acad Sci 1051:64–71CrossRefPubMed Ponyi A, Constantin T, Garami M, András C, Tállai B, Váncsa A et al (2005) Cancer-associated myositis:clinical features and prognostic signs. Ann N Y Acad Sci 1051:64–71CrossRefPubMed
8.
go back to reference Fardet L, Dupuy A, Gain M, Kettaneh A, Chérin P, Bachelez H et al (2009) Factors associated with underlying malignancy in a retrospective cohort of 121 patients with dermatomyositis. Medicine (Baltimore). 88(2):91–97CrossRefPubMed Fardet L, Dupuy A, Gain M, Kettaneh A, Chérin P, Bachelez H et al (2009) Factors associated with underlying malignancy in a retrospective cohort of 121 patients with dermatomyositis. Medicine (Baltimore). 88(2):91–97CrossRefPubMed
9.
go back to reference Lu X, Yang H, Shu X, Chen F, Zhang Y, Zhang S et al (2014) Factors predicting malignancy in patients with polymyositis and dermatomyositis: a systematic review and meta-analysis. PLoS One 9(4):e94128CrossRefPubMedPubMedCentral Lu X, Yang H, Shu X, Chen F, Zhang Y, Zhang S et al (2014) Factors predicting malignancy in patients with polymyositis and dermatomyositis: a systematic review and meta-analysis. PLoS One 9(4):e94128CrossRefPubMedPubMedCentral
10.
go back to reference Zantos D, Zhang Y, Felson D (1994) The overall and temporal association of cancer with polymyositis and dermatomyositis. J Rheumatol 21:1855–1859PubMed Zantos D, Zhang Y, Felson D (1994) The overall and temporal association of cancer with polymyositis and dermatomyositis. J Rheumatol 21:1855–1859PubMed
11.
go back to reference Hill CL, Zhang Y, Sigurgiersson B, Pukkala E, Mellemkjaer L, Airio A et al (2001) Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet 357:96–100CrossRefPubMed Hill CL, Zhang Y, Sigurgiersson B, Pukkala E, Mellemkjaer L, Airio A et al (2001) Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet 357:96–100CrossRefPubMed
12.
go back to reference Buchbinder R, Forbes A, Hall S, Dennett X, Giles G (2001) Incidence of malignant disease in biopsy-proven inflammatory myopathy. A population-based cohort study. Ann Intern Med 134:1087–1095CrossRefPubMed Buchbinder R, Forbes A, Hall S, Dennett X, Giles G (2001) Incidence of malignant disease in biopsy-proven inflammatory myopathy. A population-based cohort study. Ann Intern Med 134:1087–1095CrossRefPubMed
13.
go back to reference Stockton D, Doherty VR, Brewster DH (2001) Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study. Br J Cancer 85:41–45CrossRefPubMedPubMedCentral Stockton D, Doherty VR, Brewster DH (2001) Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study. Br J Cancer 85:41–45CrossRefPubMedPubMedCentral
15.
go back to reference Torres C, Belmonte R, Carmona L, Gómez-Reino FJ, Galindo M, Ramos B et al (2006) Survival, mortality and causes of death in inflammatory myopathies. Autoimmunity 39:205–215CrossRefPubMed Torres C, Belmonte R, Carmona L, Gómez-Reino FJ, Galindo M, Ramos B et al (2006) Survival, mortality and causes of death in inflammatory myopathies. Autoimmunity 39:205–215CrossRefPubMed
16.
go back to reference Kuo CF, See LC, Yu KH, Chou IJ, Chang HC, Chiou MJ et al (2011) Incidence, cancer risk and mortality of dermatomyositis and polymyositis in Taiwan: a nationwide population study. Br J Dermatol 165:1273–1279CrossRefPubMed Kuo CF, See LC, Yu KH, Chou IJ, Chang HC, Chiou MJ et al (2011) Incidence, cancer risk and mortality of dermatomyositis and polymyositis in Taiwan: a nationwide population study. Br J Dermatol 165:1273–1279CrossRefPubMed
17.
go back to reference Sigurgerisson B, Lindelof B, Edhag O, Allander E (1992) Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study. N Engl J Med 326:363–367CrossRef Sigurgerisson B, Lindelof B, Edhag O, Allander E (1992) Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study. N Engl J Med 326:363–367CrossRef
18.
go back to reference Liu WC, Ho M, Koh WP, Tan AW, Ng PP, Chua SH et al (2010) An 11-year review of dermatomyositis in Asian patients. Ann Acad Med Singap 39:843–847PubMed Liu WC, Ho M, Koh WP, Tan AW, Ng PP, Chua SH et al (2010) An 11-year review of dermatomyositis in Asian patients. Ann Acad Med Singap 39:843–847PubMed
19.
go back to reference Marie I, Hachulla E, Hatron PY, Hellot MF, Levesque H, Devulder B et al (2001) Polymyositis and dermatomyositis: short term and longterm outcome, and predictive factors of prognosis. J Rheumatol 28:2230–2237PubMed Marie I, Hachulla E, Hatron PY, Hellot MF, Levesque H, Devulder B et al (2001) Polymyositis and dermatomyositis: short term and longterm outcome, and predictive factors of prognosis. J Rheumatol 28:2230–2237PubMed
20.
go back to reference Wakata N, Kurihara T, Saito E, Kinoshita M (2002) Polymyositis and dermatomyositis associated with malignancy: a 30-year retrospective study. Int J Dermatol 41:729–734CrossRefPubMed Wakata N, Kurihara T, Saito E, Kinoshita M (2002) Polymyositis and dermatomyositis associated with malignancy: a 30-year retrospective study. Int J Dermatol 41:729–734CrossRefPubMed
21.
go back to reference Maoz CR, Langevitz P, Livneh A, Blumstein Z, Sadeh M, Bank I et al (1998) High incidence of malignancies in patients with dermatomyositis and polymyositis: an 11-year analysis. Semin Arthritis Rheum 27:319–324CrossRefPubMed Maoz CR, Langevitz P, Livneh A, Blumstein Z, Sadeh M, Bank I et al (1998) High incidence of malignancies in patients with dermatomyositis and polymyositis: an 11-year analysis. Semin Arthritis Rheum 27:319–324CrossRefPubMed
22.
go back to reference Airio A, Kautiainen H, Hakala M (2006) Prognosis and mortality of polymyositis and dermatomyositis patients. Clin Rheumatol 25:234–239CrossRefPubMed Airio A, Kautiainen H, Hakala M (2006) Prognosis and mortality of polymyositis and dermatomyositis patients. Clin Rheumatol 25:234–239CrossRefPubMed
23.
go back to reference Tiniakou Eleni, Mammen Andrew L (2017) Idiopathic Inflammatory myopathies and malignancy: a comprehensive review. Clin Rev Allerg Immunol 52:20–33CrossRef Tiniakou Eleni, Mammen Andrew L (2017) Idiopathic Inflammatory myopathies and malignancy: a comprehensive review. Clin Rev Allerg Immunol 52:20–33CrossRef
24.
go back to reference Yang Z, Lin F, Qin B, Liang Y, Zhong R (2015) Polymyositis/dermatomyositis and malignancy risk: a metaanalysis study. J Rheumatol 42(2):282–291CrossRefPubMed Yang Z, Lin F, Qin B, Liang Y, Zhong R (2015) Polymyositis/dermatomyositis and malignancy risk: a metaanalysis study. J Rheumatol 42(2):282–291CrossRefPubMed
25.
go back to reference Sparsa A, Liozon E, Hermann F, Ly K, Lebrun V, Soria P et al (2002) Routine vs extensive malignancy search for adult dermatomyositis and polymyositis: a study of 40 patients. Arch Dermatol 138:885–890CrossRefPubMed Sparsa A, Liozon E, Hermann F, Ly K, Lebrun V, Soria P et al (2002) Routine vs extensive malignancy search for adult dermatomyositis and polymyositis: a study of 40 patients. Arch Dermatol 138:885–890CrossRefPubMed
26.
go back to reference Inoue M, Iwasaki M, Otani T, Sasazuki S, Noda M, Tsugane S (2006) Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med 166:1871–1877CrossRefPubMed Inoue M, Iwasaki M, Otani T, Sasazuki S, Noda M, Tsugane S (2006) Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med 166:1871–1877CrossRefPubMed
27.
go back to reference Fiorentino DF, Kuo K, Chung L, Zaba L, Li S, Casciola-Rosen L (2015) Distinctive cutaneous and systemic features associated with antitranscriptional intermediary factor-1γ anti-bodies in adults with dermatomyositis. J Am Acad Dermatol 72:449–455CrossRefPubMedPubMedCentral Fiorentino DF, Kuo K, Chung L, Zaba L, Li S, Casciola-Rosen L (2015) Distinctive cutaneous and systemic features associated with antitranscriptional intermediary factor-1γ anti-bodies in adults with dermatomyositis. J Am Acad Dermatol 72:449–455CrossRefPubMedPubMedCentral
Metadata
Title
Clinical characteristics and prognosis of polymyositis and dermatomyositis associated with malignancy: a 25-year retrospective study
Authors
Kyoko Motomura
Hiroyuki Yamashita
Saeko Yamada
Yuko Takahashi
Hiroshi Kaneko
Publication date
01-10-2019
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 10/2019
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-019-04428-z

Other articles of this Issue 10/2019

Rheumatology International 10/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.